Dr. Lal PathLabs的格雷厄姆指数于March 2020触及5年低点,是282.39。 Dr. Lal PathLabs的格雷厄姆指数于2023 (359.77, -14.1%)减少和于2020 (282.39, +23.9%)、2021 (284.92, +0.9%)、2022 (419.03, +47.1%)和2024 (415.30, +15.4%)增加。 相比竞争对手,Dr. Lal PathLabs的格雷厄姆指数基准如何? 我们发现...
Dr. Lal PathLabs的下修每股收益的分析师人数,最近60天是0. 查看Dr. Lal PathLabs Ltd的下修每股收益的分析师人数,最近60天趋势、图表等
Dr. Lal PathLabs LimitedDr. Lal PathLabs Limited4.1 Disclosure by Directors and KMP's Every year, the Directors shall provide declaration to the Company Secretary his concern or interest in any Company or Companies or bodies corporate, firms, or other association of individuals in the format...
Dr Lal PathLabs Quality and Service is now being made available at your fingertips via our Mobile App, which has been made with utmost care and the objective of…
Dr Lal PathLabs, Alkem Labs IPOs priced on the higher sideLisa Pallavi Barbora
Dr Lal PathLabs Ltd (LPL) 成立于1949 年,是印度的一家大型私营临床诊断公司,在全球运营230多家实验室,每年为2500万名客户提供4000 多项诊断测试及相关健康检查和服务。LPL 专注于为患者和医生提供优质、快速和高效的测试服务,并与印度3700多家患者服务中心和9000个服务点协调合作。2017年至2018年,公司开始将业务...
Renowned Pharmacy with complete amenities. Med Shubh HealthCare is authorized, highly recommended Dr Lal PathLabs in Noida Sector-78 region
Discover the latest healthcare customer experience trends as Max Healthcare, Medanta, Dr Lal PathLabs, and more industry leaders unveil insights into patient-centric care and collaboration.
Dr Lal PathLabs Limited, a leading diagnostic and related healthcare services provider posted net profit at Rs. 96.3 crore for the second quarter ended September 30, 2021. The company's operating revenue increased by 15.4% in Q2 FY22 to Rs. 498.4 crore as compared to Rs. 431.9 crore in ...
Mincer DL, Jialal I. Hashimoto Thyroiditis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 28, 2021. Wiersinga WM. Thyroid autoimmunity. Endocr Dev. 2014;26:139-157. doi:10.1159/000363161 Balázs C. Örökletes és környezeti tényezők szerepe autoimmun pajzsm...